FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF
SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or
Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person * | 2. Issuer Name and Ticker or Trading Symbol | 5. Relationship of Reporting Person(s) to Issuer |
(Check all applicable) |
Curran Terrie | CELGENE CORP /DE/ [ CELG ] | _____ Director | _____ 10% Owner | |||||||||||||||||||||
(Last) | (First) | (Middle) | 3. Date of Earliest Transaction (MM/DD/YYYY) | |||||||||||||||||||||
__X__ Officer (give title below) _____ Other (specify below) | ||||||||||||||||||||||||
C/O CELGENE CORPORATION, 86 | 10/31/2019 | SEE REMARKS | ||||||||||||||||||||||
MORRIS AVENUE | ||||||||||||||||||||||||
(Street) | 4. If Amendment, Date Original Filed (MM/DD/YYYY) | 6. Individual or Joint/Group Filing (Check Applicable Line) | ||||||||||||||||||||||
SUMMIT, NJ 07901 | _X _ Form filed by One Reporting Person | |||||||||||||||||||||||
(City) | (State) | (Zip) | ___ Form filed by More than One Reporting Person | |||||||||||||||||||||
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||||||||||||||||
1.Title of Security | 2. Trans. Date | 2A. Deemed | 3. Trans. Code | 4. Securities Acquired (A) | 5. Amount of Securities Beneficially Owned | 6. | 7. Nature | |||||||||||||||||
(Instr. 3) | Execution | (Instr. 8) | or Disposed of (D) | Following Reported Transaction(s) | Ownership | of Indirect | ||||||||||||||||||
Date, if any | (Instr. 3, 4 and 5) | (Instr. 3 and 4) | Form: | Beneficial | ||||||||||||||||||||
Direct (D) | Ownership | |||||||||||||||||||||||
or Indirect | (Instr. 4) | |||||||||||||||||||||||
(A) or | (I) (Instr. | |||||||||||||||||||||||
Code | V | Amount | (D) | Price | 4) | |||||||||||||||||||
Common Stock | 10/31/2019 | M | 3281 | A | $0 (1)(2) | 5436 | D | |||||||||||||||||
Common Stock | 10/31/2019 | F | 1123 | D | $108.03 | 4313 | D | |||||||||||||||||
Common Stock | 926 | I | 401(k) | |||||||||||||||||||||
Plan | ||||||||||||||||||||||||
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | ||||||||||||||||||||||||
1. Title of Derivate | 2. | 3. Trans. | 3A. Deemed | 4. Trans. | 5. Number of | 6. Date Exercisable and | 7. Title and Amount of | 8. Price of | 9. Number of | 10. | 11. Nature | |||||||||||||
Security | Conversion | Date | Execution | Code | Derivative | Expiration Date | Securities Underlying | Derivative | derivative | Ownership | of Indirect | |||||||||||||
(Instr. 3) | or Exercise | Date, if any | (Instr. 8) | Securities Acquired | Derivative Security | Security | Securities | Form of | Beneficial | |||||||||||||||
Price of | (A) or Disposed of | (Instr. 3 and 4) | (Instr. 5) | Beneficially | Derivative | Ownership | ||||||||||||||||||
Derivative | (D) | Owned | Security: | (Instr. 4) | ||||||||||||||||||||
Security | (Instr. 3, 4 and 5) | Following | Direct (D) | |||||||||||||||||||||
Reported | or Indirect | |||||||||||||||||||||||
Date | Expiration | Amount or | ||||||||||||||||||||||
Title | Transaction(s) | (I) (Instr. | ||||||||||||||||||||||
Number of | ||||||||||||||||||||||||
Code | V | (A) | (D) | Exercisable | Date | Shares | (Instr. 4) | 4) | ||||||||||||||||
Restricted Stock | (1)(2) | 10/31/2019 | M | 3281 | Common | 3281 | $0 (3) | 0 | D | |||||||||||||||
Unit | Stock | |||||||||||||||||||||||
Explanation of Responses:
- The restricted stock units granted to the reporting person on October 31, 2016 have vested and settled for shares of the Company's common stock.
- Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
- The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the Company's 2008 Stock Incentive Plan).
Remarks:
PRESIDENT, GLOBAL INFLAMMATION AND IMMUNOLOGY
Reporting Owners
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Curran Terrie | ||||
C/O CELGENE CORPORATION | SEE REMARKS | |||
86 MORRIS AVENUE | ||||
SUMMIT, NJ 07901 | ||||
Signatures | ||||
/s/ Jonathan Biller, Attorney-in-Fact | 11/4/2019 |
**Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
- If the form is filed by more than one reporting person, see Instruction 4(b)(v).
- Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Attachments
- Original document
- Permalink
Disclaimer
Celgene Corporation published this content on 04 November 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 November 2019 21:39:09 UTC